Analysis of 7965 screening colonoscopies and treatment results of detected colorectal cancers – experiences of one center
Journal Title: OncoReview - Year 2016, Vol 6, Issue 3
Abstract
Introduction: Colorectal cancer is one of the most common cancers in both sexes and is one of the leading causes of death in Poland and the world. An effective method to prevent the development of colorectal cancer (CRC) is the detection of polyps during a screening colonoscopy and their removal.Objective: The aim of the study was to evaluate results of screening for early detection of colorectal cancer by colonoscopy. Material and methods: The study was based on analysis of medical records of 7965 patients who underwent colonoscopy as part of the National Screening Program (NSP) for Early Detection of Colorectal Cancer in the 2000–2014 period.Results: Polyps were removed in 2900 (36.4%) patients, among whom 1885 (23.6%) had adenomas, which were more frequent in men (32.9%). Tubular adenomas were observed in 1685 patients (21.1%), tubulo-villous adenomas were detected in 157 patients (2%) and villous adenomas – in 43 (0.5%) of them. Sixty-three (0.79%) colorectal cancers were detected in various clinical stages, including adenocarcinoma in situ in 3 patients. Probability of 5-year survival rate of colorectal cancer amounted to 74% while 10 years survival was reached in 63% of patients.Conclusions: The detection rate of polyps, adenomas and carcinomas thanks to screening colonoscopy was 36.4%, 23.6% and 0.79% respectively, while the probability of 5-year survival was 74%. An improvement in the quality of colonoscopy was observed in subsequent years of the NSP, which translated into better detection of adenomas.
Authors and Affiliations
Andrzej Nowicki, Zbigniew Kula, Marzena Lemanowicz
Late relapse of chronic myeloid leukemia after allogeneic stem cell tranplan
Chronic myeloid leukemia now is a disease which in the most cases is well manageable with tyrosine kinase inhibitors treatment. Still however the only potentially curable therapeutic approach is for chronic myeloid leuke...
Jak planuję hormonoterapię u chorego z rakiem gruczołu krokowego – spojrzenie eksperta
Rak gruczołu krokowego w ciągu ostatnich kilkudziesięciu lat stał się jednym z najczęstszych nowotworów u mężczyzn oraz jedną z głównych przyczyn zgonów na nowotwory. Ponieważ jest nowotworem hormonozależnym, od lat 40....
The New Classification of NET
There are three imporant directions in the field of GEP NET. The first one is the NET Registry which collects the data from different clinical centers, that can be compared, providing the konwledge of these tumors. The s...
Dlaczego refundacja leku sierocego wymaga szczególnego podejścia?
Największym problemem dotyczącym refundacji produktów sierocych jest ich wysoka cena. Decyzje refundacyjne i cenowe w przypadku leków sierocych są szczególnie mocno powiązane. Jeśli dotyczą nowo wprowadzanych na rynek te...
High risk pulmonary embolism in oncology
Pulmonary embolism is a frequent complication of both cancer and the oncologic therapy. There is still discussed the subject of optimal antithrombotic prophylaxis in oncology. This article presents the patient with metas...